Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

WAY-100135

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
WAY-100135
Clinical data
ATC code
  • None
Identifiers
  • (S)-N-tert-Butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC24H33N3O2
Molar mass395.547 g·mol−1
3D model (JSmol)
  • c2ccccc2C(C(=O)NC(C)(C)C)CN(CC3)CCN3c1ccccc1OC
  • InChI=1S/C24H33N3O2/c1-24(2,3)25-23(28)20(19-10-6-5-7-11-19)18-26-14-16-27(17-15-26)21-12-8-9-13-22(21)29-4/h5-13,20H,14-18H2,1-4H3,(H,25,28) ☒N
  • Key:UMTDAKAAYOXIKU-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

WAY-100135 is aserotonergicdrug of thephenylpiperazine family which is used inscientific research.[1] It acts aspotent5-HT1A receptorantagonist,[2] and was originally believed to be highlyselective, but further studies have demonstrated that it also acts as apartial agonist of the5-HT1D receptor (pKi = 7.58; virtually the same affinity for 5-HT1A), and to a much lesser extent, of the5-HT1B receptor (pKi = 5.82).[3] These findings may have prompted the development of the related compoundWAY-100635, another purportedly selective and even more potent 5-HT1A antagonist, which was synthesized shortly thereafter.[4] However, WAY-100635 turned out to be non-selective as well, having been shown to act additionally as a potentD4 receptoragonist later on.[5]

See also

[edit]

References

[edit]
  1. ^Fletcher A, Bill DJ, Bill SJ, et al. (June 1993). "WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors".European Journal of Pharmacology.237 (2–3):283–91.doi:10.1016/0014-2999(93)90280-u.PMID 8365456.
  2. ^Cliffe IA, Brightwell CI, Fletcher A, et al. (May 1993). "(S)-N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptors".Journal of Medicinal Chemistry.36 (10):1509–10.doi:10.1021/jm00062a028.PMID 8496920.
  3. ^Davidson C, Ho M, Price GW, Jones BJ, Stamford JA (June 1997)."(+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors".British Journal of Pharmacology.121 (4):737–42.doi:10.1038/sj.bjp.0701197.PMC 1564750.PMID 9208142.
  4. ^Fornal CA, Metzler CW, Gallegos RA, Veasey SC, McCreary AC, Jacobs BL (August 1996)."WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135".The Journal of Pharmacology and Experimental Therapeutics.278 (2):752–62.PMID 8768728.
  5. ^Chemel BR,Roth BL, Armbruster B, Watts VJ, Nichols DE (October 2006). "WAY-100635 is a potent dopamine D4 receptor agonist".Psychopharmacology.188 (2):244–51.doi:10.1007/s00213-006-0490-4.PMID 16915381.S2CID 24194034.
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Simple piperazines
(no additional rings)
Phenylpiperazines
Benzylpiperazines
Diphenylalkylpiperazines
(benzhydrylalkylpiperazines)
Pyrimidinylpiperazines
Pyridinylpiperazines
Benzo(iso)thiazolylpiperazines
Tricyclics
(piperazine attached via side chain)
Others/Uncategorized
Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=WAY-100135&oldid=1270925309"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp